Skip to main content

ACI's 16th National Rx Drug Pricing Master Course

American Conference Institute

Nov
2
2016

Date: November 2, 2016

Time: 3:00PM

Location: Park Lane Hotel New York, NY

Topics

  • Developing a Culture of Pricing Compliance - Strategies for Avoiding OIG and DOJ Scrutiny of Drug Pricing Practices
     

Mintz Levin's Bill Davis will speak on the panel, "Developing a Culture of Pricing Compliance - Strategies for Avoiding OIG and DOJ Scrutiny of Drug Pricing Practices," at ACI's 16th National Rx Drug Pricing Master Course.

Panel Description

• Understanding the current environment for compliance and enforcement related to pricing issues

• Identifying compliance guidance for pricing issues

• Anatomy of a government False Claims Act and Anti-Kickback investigations

• Identifying the roles of CMS, OIG and DOJ relative to pricing, rebates and enforcement

• Acknowledging the OIG’s direct pricing authority to determine and force WAMP (widely available market price) as an alternative to ASP

• Comprehending the OIG’s indirect impact on pricing

• Coupons

• Part D rebates and administrative fees

• Assessing potential anti-kickback violations with treatment of payment support programs for price reporting

• Bolstering compliance programs and internal practices to minimize the risk of investigations

• Analyzing enforcement trends

  • False claims act cases
  • Bundling cases

• Responding to government investigations

• Assessing the collateral consequences of investigations

Speakers

Professional Cropped Davis William Mintz

William A. Davis

Panelist

William A. Davis is an integral member of the Health Care Enforcement Defense Group at Mintz. He litigates disputes concerning prescription drug price reporting, distribution, reimbursement, and rebates. Bill is also the DC leader of Mintz’s Litigation Practice.